Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACLX | RARE | ADMA | ||
| Company | Arcellx Inc | Ultragenyx Pharmaceu | Adma Biologics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 80.22 | 50.09 | 19.08 | ||
| High | 87.74 | 52.19 | 19.25 | ||
| Low | 77.00 | 49.89 | 18.57 | ||
| Last | 87.12 | 52.18 | 18.83 | ||
| Change | +0.68 | +1.12 | -0.28 | ||
| % Change | +0.79% | +2.19% | -1.47% | ||
| Volume | 2,330,800 | 1,749,500 | 2,215,900 | ||
| 20-Day Average Volume | 592,160 | 726,485 | 4,936,810 | ||
| Previous Close | 86.44 | 51.06 | 19.11 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 87.83 | 54.10 | 16.91 | ||
| 20-Day Raw Stochastic | 49.27% | 28.69% | 60.34% | ||
| 20-Day Relative Strength | 56.08% | 43.64% | 57.22% | ||
| Weighted Alpha | +91.81 | +41.19 | +272.21 | ||
| Today's Opinion | 80% Buy | 40% Buy | 80% Buy | ||
| Previous Opinion | 80% Buy | 40% Buy | 80% Buy | ||
| Last Month's Opinion | 88% Buy | 56% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.15% since 10/29/24 | -1.17% since 10/29/24 | +12.69% since 10/29/24 | ||
| Low | 77.00 on 11/05/24 | 49.84 on 11/04/24 | 16.09 on 10/31/24 | ||
| High | 91.20 on 11/04/24 | 53.19 on 10/30/24 | 20.18 on 11/01/24 | ||
| 1-Month | |||||
| %Chg | +11.36% since 10/04/24 | -2.99% since 10/04/24 | -7.20% since 10/04/24 | ||
| Low | 75.15 on 10/07/24 | 49.84 on 11/04/24 | 15.33 on 10/21/24 | ||
| High | 97.54 on 10/18/24 | 57.99 on 10/16/24 | 21.13 on 10/09/24 | ||
| 3-Month | |||||
| %Chg | +70.52% since 08/05/24 | +6.32% since 08/05/24 | +66.64% since 08/05/24 | ||
| Low | 50.29 on 08/07/24 | 48.19 on 08/08/24 | 11.22 on 08/06/24 | ||
| High | 97.54 on 10/18/24 | 60.37 on 09/16/24 | 21.13 on 10/09/24 | ||
| 6-Month | |||||
| %Chg | +65.34% since 05/03/24 | +22.06% since 05/03/24 | +176.51% since 05/03/24 | ||
| Low | 47.88 on 05/10/24 | 37.02 on 06/18/24 | 6.72 on 05/08/24 | ||
| High | 97.54 on 10/18/24 | 60.37 on 09/16/24 | 21.13 on 10/09/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,646,669 | 4,705,945 | 4,454,216 | ||
| Shares Outstanding, K | 53,756 | 92,165 | 233,083 | ||
| Annual Sales | 110,320,000 | 434,250,000 | 258,220,000 | ||
| Annual Net Income | -70,690,000 | -606,640,000 | -28,240,000 | ||
| Last Quarter Sales | 27,380,000 | 147,030,000 | 107,190,000 | ||
| Last Quarter Net Income | -27,200,000 | -131,600,000 | 32,060,000 | ||
| 60-Month Beta | 0.27 | 0.58 | 0.64 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.51 on 08/08/24 | -1.52 on 08/01/24 | 0.13 on 08/08/24 | ||
| Latest Earnings Date | 11/11/24 | 11/05/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 74.50 | ||